SCHEMBL22173453

SCHEMBL22173453

c1ccc(-c2cccc(-c3cccc(-c4cccc(-c5ccc(-c6cccc(-c7cccc(-n8c9ccccc9c9cc(-c%10ccc%11c(c%10)c%10ccccc%10n%11-c%10ccccc%10)ccc98)c7)c6)cc5)c4)c3)c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.58
▸ L3MBTL1 Q9Y468 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ TSPO P30536 3/20 0.43
▸ KMT2A Q03164 2/20 0.41
▸ IL1R1 P14778 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ FAAH O00519 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ MGLL Q99685 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HTR1A P08908 1/20 0.38
▸ HTR7 P34969 1/20 0.38
▸ PTGER4 P35408 1/20 0.38
▸ DNM1 Q05193 1/20 0.37
▸ AVPR1A P37288 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22172912 1.00 ATM (0.58) ATML3MBTL1KDM4ETSPOKMT2A
SCHEMBL22172913 1.00 ATM (0.58) ATML3MBTL1KDM4ETSPOKMT2A
SCHEMBL22173173 1.00 ATM (0.58) ATML3MBTL1KDM4ETSPOKMT2A
SCHEMBL22173127 1.00 ATM (0.58) ATML3MBTL1KDM4ETSPOKMT2A
SCHEMBL22173176 1.00 ATM (0.58) ATML3MBTL1KDM4ETSPOKMT2A
SCHEMBL22173172 1.00 ATM (0.58) ATML3MBTL1KDM4ETSPOKMT2A
SCHEMBL22173289 1.00 ATM (0.58) ATML3MBTL1KDM4ETSPOKMT2A
SCHEMBL22173451 1.00 ATM (0.58) ATML3MBTL1KDM4ETSPOKMT2A
SCHEMBL22173126 1.00 ATM (0.58) ATML3MBTL1KDM4ETSPOKMT2A
SCHEMBL22173285 1.00 ATM (0.58) ATML3MBTL1KDM4ETSPOKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230140682-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO LTD (KR) 2023-05-04 — — US disclosed
US-20230140682-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO LTD (KR) 2023-05-04 — — US disclosed
US-11542252-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-01-03 — — US disclosed
US-20200207739-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542252-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CCNT1, CCNA1, CYP1B1 ATM 1887/4885L3MBTL1 175/4885KDM4E 3931/4885
US-20230140682-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CCNT1, CCNA1, CYP1B1 ATM 1887/4885L3MBTL1 175/4885KDM4E 3931/4885
US-20200207739-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CCNT1, CCNA1, CYP1B1 ATM 1887/4885L3MBTL1 175/4885KDM4E 3931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback